Table 3:
Statistical analysis of EMD and FD processing results shown in Figure 5.
| Outcomes | Mean (S.D.) | Parametric F test p-value | Post-hoc T tests | Non-parametric Kruskal Wallis test p-value | ||||
|---|---|---|---|---|---|---|---|---|
| MF | NF | EMD | EMD vs. MF | EMD vs. NF | NF vs. MF | |||
| COUNT | 898525 (329107) | 130613 (103428) | 271450 (58106) | 0.0010 | 0.0045 | 0.6032 | 0.0012 | 0.0125 |
| VIABILITY | 90.8 (5.2) | 90.5 (6.3) | 92.6 (4.2) | 0.8330 | 0.8823 | 0.8406 | 0.9959 | 0.7939 |
| Population (%, normalized to MF) | ||||||||
| CD34 | 1.2 (0.3) | 2.7 (1.3) | 0.0745 | 0.0745 | 0.0209 | |||
| MSC | 1.3 (0.1) | 1.9 (0.5) | 0.0373 | 0.0373 | 0.0209 | |||
| EPC | 2.2 (0.2) | 5.5 (3.1) | 0.0755 | 0.0755 | 0.0209 | |||
| MUSE | 1.2 (0.6) | 1.6 (0.3) | 0.2580 | 0.2580 | 0.3865 | |||
| DPP4 | 0.8 (0.4) | 1.5 (0.4) | 0.0393 | 0.0393 | 0.0209 | |||
| Cell number (normalized to MF) | ||||||||
| CD34 | 0.2 (0.2) | 0.9 (0.6) | 0.0552 | 0.0552 | 0.0209 | |||
| MSC | 0.2 (0.1) | 0.6 (0.2) | 0.0197 | 0.0197 | 0.0209 | |||
| EPC | 0.3 (0.2) | 1.8 (1.3) | 0.0676 | 0.0676 | 0.0209 | |||
| MUSE | 0.2 (0.2) | 0.5 (0.1) | 0.0488 | 0.0488 | 0.0833 | |||
| DPP4 | 0.1 (0.1) | 0.5 (0.2) | 0.0139 | 0.0139 | 0.0209 | |||